業績公告
即時報告
8-K
2026-05-14
CapsoVision 提交8-K公告2026財年第一季業績 投資者可參閱新聞稿了解詳情
AI 繁中摘要
CapsoVision, Inc. 於 2026 年 5 月 14 日提交 8-K 申報文件，公佈截至 2026 年 3 月 31 日的第一季度（2026 財年第一季）財務業績。公司當日發佈新聞稿（附件 99.1），內容涵蓋季度營運及財務狀況重點。有關資料僅作「提供」（furnished）性質，不視為已「申報」（filed），亦不納入其他 SEC 文件引用。CapsoVision 為新興成長公司，普通股（代號 CV）於納斯達克掛牌。投資者可參閱新聞稿了解具體收入、盈利及業務進展，雖無詳細數字披露於 8-K 正文，但管理層通常會在相關新聞稿中說明季度表現及前景。此舉屬常規季度業績公告，對股價及市場情緒或有短期影響。
展開英文正文
cv-20260514FALSE000137832500013783252025-05-142027-03-14 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________ FORM 8-K _________________________ CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 14, 2026 _________________________ CapsoVision, Inc. (Exact name of registrant as specified in its charter) _________________________ Delaware001-4270520-3369494 (State or other jurisdiction of incorporation)(Commission File Number)(IRS Employer Identification Number) 18805 Cox Avenue, Suite 250 Saratoga, California 95070 (Address of Principal Executive Offices)(Zip Code) Registrant’s telephone number, including area code: (408)-624-1488 n/a (Former Name or Former Address, if Changed Since Last Report) _________________________ Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: oWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) oSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) oPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) oPre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each classTrading SymbolName of each exchange on which registered common stock, $0.001 par value per shareCVThe Nasdaq Stock Market LLC Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☒ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 2.02. Results of Operations and Financial Condition. On May 14, 2026, the Company issued a press release announcing its financial results for the fiscal quarter ended March 31, 2026. A copy of the press release, dated May 14, 2026, is furnished hereto as Exhibit 99.1 and is incorporated herein by reference. The foregoing information in this Item 2.02 (including the exhibit hereto) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing. Item 9.01 Financial Statements and Exhibits. The following exhibits are being filed herewith: Exhibit No.Description 99.1Press Release of CapsoVision, Inc, dated May 14, 2026. 104Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CAPSOVISION, INC. Date: May 14, 2026By:/s/ Kang-Huai (Johnny) Wang Name:Kang-Huai (Johnny) Wang TitleDirector, President and Chief Executive Officer